CVS Health Management
Management criteria checks 3/4
CVS Health's CEO is J. Joyner, appointed in Oct 2024, has a tenure of 1.5 years. total yearly compensation is $21.21M, comprised of 7.1% salary and 92.9% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $5.58M. The average tenure of the management team and the board of directors is 3.2 years and 3 years respectively.
Key information
J. Joyner
Chief executive officer
US$21.2m
Total compensation
| CEO salary percentage | 7.07% |
| CEO tenure | 1.5yrs |
| CEO ownership | 0.005% |
| Management average tenure | 3.2yrs |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
CVS Health: A Diversified Income Play With Improving MA Rate Visibility For 2027
Apr 08CVS Health's (NYSE:CVS) Soft Earnings Don't Show The Whole Picture
Aug 13
CVS Health: I Don't Understand The Fuss, But The Worst Is Behind
Mar 30CVS Health: Incremental Improvement Best Hope For 2025 (Rating Downgrade)
Feb 26CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Feb 13CVS Health Isn't Going To The Dogs
Jan 17CVS Health: An Attractive 5.8% Safe Yield For Now
Jan 10CVS Health: When The Industry Is In Crisis, Don't Pick The Weaker Players
Dec 10CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06Why CVS’s Valuation Signals Opportunity
CVS Health has just faced a stock decline of about 10% after its preliminary Q3 earnings miss, which made the entire market aware. The decline is contributed largely to a $1.1 billion charge connectedCVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | US$21m | US$2m | US$2b |
| Sep 30 2025 | n/a | n/a | US$469m |
| Jun 30 2025 | n/a | n/a | US$5b |
| Mar 31 2025 | n/a | n/a | US$5b |
| Dec 31 2024 | US$18m | US$1m | US$5b |
Compensation vs Market: J.'s total compensation ($USD21.21M) is above average for companies of similar size in the US market ($USD14.21M).
Compensation vs Earnings: J.'s compensation has been consistent with company performance over the past year.
CEO
J. Joyner (60 yo)
Mr. J. David Joyner is CEO, President & Director of CVS Health Corporation from October 17, 2024 and served as Executive Vice President from January 30, 2023 to October 17, 2024 and also serves as Chairman...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman | 1.5yrs | US$21.21m | 0.0055% $ 5.6m | |
| Executive VP & CFO | less than a year | US$9.82m | 0% $ 0 | |
| EVP of Ventures and Chief Experience & Technology Officer | 3.8yrs | US$10.98m | 0.0062% $ 6.3m | |
| Executive VP & Group President | 4.4yrs | US$13.38m | 0.0054% $ 5.5m | |
| Executive VP & President of Aetna | 1.4yrs | US$11.59m | 0.00023% $ 233.8k | |
| Senior VP | 7.4yrs | no data | 0.0012% $ 1.2m | |
| Executive VP & Chief Compliance Officer | no data | no data | no data | |
| Executive VP | 3.2yrs | US$11.89m | 0.0026% $ 2.7m | |
| Executive VP & Chief People Officer | 1.6yrs | US$6.85m | 0.0010% $ 1.0m | |
| Executive Director | less than a year | US$305.00k | 0.0015% $ 1.5m | |
| Head of Markets of Healthcare Benefits | 4.2yrs | no data | no data | |
| Chief Sustainability Officer & Senior VP of Corporate Social Responsibility | 3.2yrs | no data | no data |
Experienced Management: CVS's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman | 1.5yrs | US$21.21m | 0.0055% $ 5.6m | |
| Executive Director | 7.4yrs | US$305.00k | 0.0015% $ 1.5m | |
| Independent Director | 2.5yrs | US$335.00k | 0.0010% $ 1.0m | |
| Independent Director | 1.4yrs | US$335.00k | 0% $ 0 | |
| Independent Director | 15.3yrs | US$347.50k | 0.0018% $ 1.8m | |
| Independent Director | 19.1yrs | US$360.00k | 0.010% $ 10.1m | |
| Independent Director | 11.1yrs | US$335.00k | 0.00023% $ 233.8k | |
| Independent Director | 1.4yrs | US$335.00k | 0.0011% $ 1.1m | |
| Independent Director | 7.4yrs | US$365.00k | 0.0032% $ 3.3m | |
| Independent Director | 3.6yrs | US$360.00k | 0.0011% $ 1.1m | |
| Director | 1.4yrs | US$335.00k | 0.00046% $ 467.7k | |
| Lead Independent Director | 2.4yrs | US$421.67k | 0.0036% $ 3.6m |
Experienced Board: CVS's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/13 09:57 |
| End of Day Share Price | 2026/04/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Health Corporation is covered by 48 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harshit Gupta | Accountability Research Corporation |
| Christopher Graja | Argus Research Company |
| Hua Ha | Baird |